The tweet was deleted by the author.
But we saved everything 🙂.
CVRx has appointed Michael Dale as a new member of its Board of Directors.
Dale brings decades of leadership experience in the medical device sector and is known for a strong track record in driving growth and innovation. The company expressed confidence that his insights and strategic guidance will benefit its board and overall strategy moving forward.
View post on X Loading...
CVRx has recently marked the completion of 50 Barostim implants at Wellstar Kennestone, advancing its presence in heart failure treatment options, according to a company announcement. The company is also focusing on clinical integration with plans to host a Barostim symposium at AAHFN2026 for advanced practice providers, as stated in an earlier update. These initiatives reflect ongoing efforts to expand Barostim adoption.